The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – Guggenheim upgraded Quanta Services (PWR) to Buy from Neutral with an $800 price target. A “strong” Q2 report “validates the underlying value premise rather than simply reflecting a favorable outcome for the quarter,” says the firm, which has raised estimates “substantially” for 2027-2030. – Stifel upgraded Saia (SAIA) to Buy from Hold with a price target of $438, down from $450. There was “noise” in reported KPIs that led to some confusion amongst investors and the Street, but the firm believes they “should be focused” on revenue per shipment, contract renewals, above-seasonal operating ratio trends and record service levels, as these are “the enabler of core pricing.” – Piper Sandler upgraded Replimune (REPL) to Overweight from Neutral with a price target of $14, up from $9.
The postive FDA panel vote supporting RP1 approval for advanced melanoma after anti-PD-1 failure “makes approval the most likely outcome of the BLA’s third review,” the firm tells investors. Cantor Fitzgerald also upgraded Replimune to Overweight from Neutral without a price target citing the FDA panel vote supporting RP1 approval for advanced melanoma after anti-PD-1 failure. – BMO Capital upgraded Nextpower (NXT) to Outperform from Market Perform with an unchanged price target of $132, offering 36% upside. The recent selloff has created an “attractive opportunity to own what we view as one of the highest-quality utility-scale solar platforms,” the firm tells investors in a research note. – Deutsche Bank upgraded International Paper (IP) to Buy from Hold with a price target of $50, up from $39.